Rab32/Rab38-positive Lysosome-Related Organelle degrades lipid droplet in hepatocytes by microautophagy

This study identifies Rab32 and Rab38-positive lysosome-related organelles as the specific structural platforms in hepatocytes that mediate lipid droplet degradation via a microautophagy mechanism involving PI3P/PI(3,5)P2 and Vps4B.

The Gist

The Big Picture: A Cellular "Recycling Center" That Got Lost

Imagine your liver cells (hepatocytes) as busy, high-tech factories. Their job is to manage energy. When you eat, they store excess energy in little bubbles called Lipid Droplets (LDs). Think of these droplets as storage tanks of fuel (like oil or fat).

When the factory needs energy, it has to break down these storage tanks. Usually, we know about two ways the factory does this:

1. The "Big Truck" method (Macroautophagy): A large container wraps around the fuel tank and drives it to the recycling plant.
2. The "Direct Drop-off" method: The fuel tank is handed directly to the recycling plant.

This paper discovered a third, hidden method. The researchers found that liver cells have a special, upgraded version of the recycling plant called a Lysosome-Related Organelle (LRO). It's like a specialized "Super-Recycler" that doesn't just wait for trucks; it actively reaches out, grabs the fuel tanks, and swallows them whole using a process called microautophagy.

The Key Players: The "Managers" (Rab32 and Rab38)

Every good factory needs managers to keep things running. In this study, the managers are two proteins named Rab32 and Rab38.

• What they do: These managers patrol the factory floor. They identify the "Super-Recyclers" (LROs) and make sure they are big enough and ready to work.
• The Analogy: Imagine Rab32 and Rab38 are the foremen who tell the recycling bins, "Hey, expand your size! Get ready to eat!" Without these foremen, the recycling bins stay small and useless.

What Happened When the Managers Were Fired? (The Experiments)

The scientists decided to see what happens if they remove these managers (by creating mice and cells without Rab32 and Rab38).

1. The Factory Got Clogged: Without the managers, the "Super-Recyclers" couldn't grow big enough to do their job.
2. Fuel Piled Up: The storage tanks (lipid droplets) couldn't get broken down. They started piling up inside the cells.
3. The Mice Got Fat: The mice without these managers started gaining weight as they got older. Their livers became fatty, and they were much more likely to get obese if fed a high-fat diet.
   • Metaphor: It's like a city where the garbage trucks stop working. The trash (fat) piles up on the streets, and eventually, the whole city (the mouse) gets covered in garbage.

How the "Super-Recycler" Eats (Microautophagy)

The researchers watched the cells in real-time and saw something fascinating.

• The Process: Instead of wrapping the fuel tank in a new container, the "Super-Recycler" (the LRO) actually invaginates (folds inward) like a Pac-Man opening its mouth. It reaches out, grabs the lipid droplet, and pulls it inside its own walls to digest it.
• The "Glue" (PI3P and PI(3,5)P₂): To make this mouth open and close correctly, the cell uses special chemical "glue" (phospholipids). The study found that if you remove this glue, the mouth can't open, and the fuel tank can't get inside.
• The "Scissors" (VPS4B): There is also a molecular pair of scissors (a protein called VPS4B) that helps cut the membrane after the fuel is grabbed. Without these scissors, the process gets stuck.

Why Macroautophagy Didn't Matter Here

For a long time, scientists thought the "Big Truck" method (macroautophagy) was the main way cells ate fat. But this study proved that even if you stop the "Big Trucks" completely, the "Super-Recyclers" (LROs) can still eat the fat on their own.

• Analogy: It's like discovering that even if the main highway is closed, the city still has a secret underground tunnel system that can deliver supplies just fine. The "Super-Recyclers" don't need the big trucks; they have their own direct access.

The Takeaway for Humans

This research is a big deal because it changes how we understand obesity and fatty liver disease.

• The Problem: We often think we just need to stop eating fat or speed up the "Big Truck" recycling.
• The New Insight: We might also need to fix the "Super-Recyclers." If the managers (Rab32/38) are missing or broken, the liver can't clear out fat, leading to disease.

In short: Your liver has a secret, specialized recycling bin that eats fat directly. This bin needs two specific managers (Rab32 and Rab38) to grow big enough to do the job. If those managers are missing, the fat piles up, and you get fat. Understanding this new "eating" mechanism could help us find better ways to treat fatty liver disease and obesity in the future.

Technical Summary

1. Problem Statement

Lipid droplets (LDs) are essential organelles for energy storage and homeostasis. In hepatocytes, LD turnover occurs via cytosolic lipolysis and lysosome-dependent degradation. While macroautophagy-mediated "lipophagy" and direct LD-lysosome interactions (e.g., via LAMP2B) are known, the specific mechanisms and organelle identity of specialized lysosomal compartments involved in LD degradation remain unclear. Specifically, the role of Rab32 and Rab38—small GTPases previously characterized for their role in melanosome biogenesis (a type of lysosome-related organelle or LRO) in pigment cells—in hepatic lipid metabolism was undefined. The study aimed to determine if hepatocytes possess Rab32/38-positive LROs and whether these organelles mediate LD degradation via microautophagy.

2. Methodology

The researchers employed a multi-faceted approach combining cell biology, pharmacology, genetics, and in vivo mouse models:

• Cell Models: Used the murine hepatocyte cell line AML12. Cell confluence was manipulated (low ~30% vs. high ~80%) to observe changes in organelle morphology.
• Genetic Manipulation:
  • Knockdown (DKD/SKD): Used shRNA to create Rab32, Rab38, and double-knockdown (DKD) AML12 cells.
  • Knockout (DKO): Utilized previously generated Rab32/38 double-knockout (DKO) mice (C57BL/6J background).
  • Overexpression: Generated stable lines expressing GFP-Rab32/38, LAMP1-RFP, and various reporters (e.g., mCherry-GFP-PLIN2 for LD tracking).
• Pharmacological Inhibition:
  • Orlistat: Inhibited lysosomal acid lipase to block LD degradation, causing LD accumulation within organelles.
  • Bafilomycin A1: Inhibited V-ATPase to prevent acidification, revealing membrane invagination structures.
  • SAR405: Inhibited Vps34 to block PI3P production.
  • Apilimod: Inhibited PIKfyve to block PI(3,5)P₂ synthesis.
  • Atg4B C74A: Overexpression of an inactive mutant to specifically block macroautophagy.
• Imaging & Analysis:
  • Confocal Microscopy: Live-cell and fixed-cell imaging using specific dyes (Lipi-Blue, Lipi Deep Red, LysoTracker, Dextran-Rhodamine) and fluorescent protein fusions.
  • Biochemical Assays: Western blotting for protein levels (Rab32/38, LC3, p62) and enzymatic assays for serum and liver triacylglycerol (TAG) levels.
  • In Vivo Studies: Male DKO and Wild-Type (WT) mice were fed a high-fat diet (HFD) for 12 weeks to assess susceptibility to obesity and hepatic steatosis.

3. Key Contributions

• Identification of Hepatic LROs: The study establishes that hepatocytes contain Rab32/38-positive Lysosome-Related Organelles (LROs) that are distinct from classical lysosomes. These LROs are large, ring-like, LAMP1-positive structures that expand with cell confluence.
• Mechanism of LD Degradation: It demonstrates that these LROs degrade LDs via microautophagy (direct membrane invagination) rather than macroautophagy.
• Molecular Regulation: The study elucidates the phosphoinositide signaling pathway (PI3P $\to$ PI(3,5)P₂) and the ESCRT machinery component VPS4B as critical regulators of LD engulfment by LROs.
• Physiological Relevance: It links the loss of Rab32/38 to age-dependent hepatic lipid accumulation and increased susceptibility to diet-induced obesity in mice.

4. Key Results

A. Characterization of Rab32/38-positive LROs

• In AML12 cells, Rab32 and Rab38 localize to large, ring-like structures that colocalize with LAMP1 and Rab7 (late endosome marker) but not Rab5.
• The size and number of these LROs increase with cell confluence (from ~30% to ~80%).
• Double-knockdown (DKD) of Rab32/38 significantly reduces the formation of these large vacuoles, while overexpression promotes them.

B. Microautophagy-Mediated LD Degradation

• Orlistat Treatment: Inhibiting lysosomal acid lipase causes LDs to accumulate inside Rab32/38-positive LROs, confirming these organelles are the site of LD degradation.
• Membrane Remodeling: Treatment with Bafilomycin A1 revealed that LDs are engulfed via membrane invaginations (single or multilayered) within the LRO lumen.
• Independence from Macroautophagy: Even when macroautophagy was completely blocked (using Atg4B C74A overexpression), LDs were still engulfed by Rab32/38-LROs. This confirms the process is microautophagy.

C. Molecular Mechanism: Phosphoinositides and ESCRT

• Phosphoinositides: PI3P (visualized by 2×FYVE probe) and PI(3,5)P₂ (visualized by PX-SnxAGV-GCC probe) are enriched at the sites of LD incorporation.
  • Inhibition of Vps34 (SAR405) abolished PI3P rings and prevented LD entry.
  • Inhibition of PIKfyve (Apilimod) prevented PI(3,5)P₂ formation and disrupted the process.
• ESCRT Machinery: Knockdown of VPS4B (but not VPS4A) significantly impaired LD delivery into Rab32/38-LROs and caused LRO enlargement, suggesting VPS4B is essential for the membrane scission/remodeling required for LD engulfment.

D. Differential Roles of Rab32 and Rab38

• Rab32 KD: Led to the accumulation of enlarged LDs.
• Rab38 KD: Led to the accumulation of numerous small LDs.
• DKD: Showed the most severe defect in LD engulfment into LROs, indicating both proteins are required for efficient clearance, potentially at different stages of LD turnover.

E. In Vivo Phenotypes

• Age-Dependent Obesity: Male Rab32/38 DKO mice showed increased body weight and white adipose tissue (WAT) accumulation at 12 months compared to WT.
• Hepatic Steatosis: DKO livers appeared darker with brown granules (lipofuscin) and showed increased hepatic TAG levels, especially under High-Fat Diet (HFD) conditions.
• Serum TAG: Interestingly, serum TAG levels were not elevated in DKO mice, suggesting impaired mobilization/export of lipids from the liver due to defective degradation.

5. Significance

This study fundamentally expands the understanding of hepatic lipid metabolism by:

1. Defining a New Pathway: Identifying a microautophagy-mediated pathway for LD degradation that operates independently of the canonical macroautophagy system.
2. Reclassifying Organelles: Establishing that hepatocytes utilize Rab32/38-positive LROs (previously thought to be specific to pigment cells or osteoclasts) as specialized compartments for lipid catabolism.
3. Therapeutic Implications: Highlighting the Rab32/38-VPS4B axis as a potential target for treating metabolic disorders like Non-Alcoholic Fatty Liver Disease (NAFLD/MASLD) and obesity. The findings suggest that defects in LRO-mediated microautophagy contribute to age-related metabolic decline and diet-induced obesity.
4. Mechanistic Insight: Providing a detailed molecular map involving PI3P/PI(3,5)P₂ signaling and ESCRT machinery that drives the membrane remodeling necessary for organelle quality control in the liver.